PT  - JOURNAL ARTICLE
AU  - Yang, Zhiqi
AU  - Lin, Daiying
AU  - Chen, Xiaofeng
AU  - Qiu, Jinming
AU  - Li, Shengkai
AU  - Huang, Ruibin
AU  - Sun, Hongfu
AU  - Liao, Yuting
AU  - Xiao, Jianning
AU  - Tang, Yanyan
AU  - Liu, Guorui
AU  - Wu, Renhua
AU  - Chen, Xiangguang
AU  - Dai, Zhuozhi
TI  - Distinguishing COVID-19 from influenza pneumonia in the early stage through CT imaging and clinical features
AID  - 10.1101/2020.04.17.20061242
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.17.20061242
4099  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20061242.short
4100  - http://medrxiv.org/content/early/2020/04/22/2020.04.17.20061242.full
AB  - Purpose To identify differences in CT imaging and clinical features between COVID-19 and influenza pneumonia in the early stage, and to identify the most valuable features in the differential diagnosis.Materials and Method A consecutive cohort of 73 COVID-19 and 48 influenza pneumonia patients were retrospectively recruited from five independent institutions. The courses of both diseases were confirmed to be in the early stages (2.66 ± 2.62 days for COVID-19 and 2.19 ± 2.10 days for influenza pneumonia after onset). The chi-square test, student’s t-test, and Kruskal-Wallis H-test were performed to compare CT imaging and clinical features between the two groups. Spearman or Kendall correlation tests between feature metrics and diagnosis outcomes were also assessed. The diagnostic performance of each feature in differentiating COVID-19 from influenza pneumonia was evaluated with univariate analysis. The corresponding area under the curve (AUC), accuracy, specificity, sensitivity and threshold were reported.Results The ground-glass opacification (GGO) was the most common imaging feature in COVID-19, including pure-GGO (75.3%) and mixed-GGO (78.1%), mainly in peripheral distribution. For clinical features, most COVID-19 patients presented normal white blood cell (WBC) count (89.04%) and neutrophil count (84.93%). Twenty imaging features and 6 clinical features were identified to be significantly different between the two diseases. The diagnosis outcomes correlated significantly with the WBC count (r=-0.526, P<0.001) and neutrophil count (r=-0.500, P<0.001). Four CT imaging features had absolute correlations coefficients higher than 0.300 (P<0.001), including crazy-paving pattern, mixed-GGO in peripheral area, pleural effusions, and consolidation.Conclusions Among a total of 1537 lesions and 62 imaging and clinical features, 26 features were demonstrated to be significantly different between COVID-19 and influenza pneumonia. The crazy-paving pattern was recognized as the most powerful imaging feature for the differential diagnosis in the early stage, while WBC count yielded the highest diagnostic efficacy in clinical manifestations.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by grants from the Natural Science Foundation of China [grant number 81471730, 31870981] to R.W.; the 2020 LKSF cross-disciplinary research grants [grant number 2020LKSFBME06]; the Natural Science Foundation of Guangdong Province [grant number 2018A030307057] to Z.D.; and the Special Project on Prevention and Control of COVID-19 for Colleges and Universities in Guangdong Province (grant number 2020KZDZX1085) to Z.D.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data are available from the authors upon reasonable request.COVID-19coronavirus disease 2019GGOground-glass opacityRT-PCRreverse transcription polymerase chain reactionWBCwhite blood cellCRPC-reactive proteinAUCarea under the curveSARSsevere acute respiratory syndromeMERSmiddle east respiratory syndrome.